|
Sling is racing to market the first oral IGF-1R blocker, which would likely provide competition to Amgen’s Tepezza.
|
 |
|
The approval of pitolisant in Japan is based on domestic Phase III studies and international clinical research evidence.
|
|
|
The partnership aims to assist GenomeFrontier’s clinical activities for GF-CART01 in the US.
|
|
|
The CRDMO has revamped its leadership and is building capacity as it eyes growth and emerging modalities.
|
|
|
For the purpose of this single-centre observational study, 82 patients who were prospectively treated with biologics were included.
|
|
